Stock listing
Munich:TCE2 Celldex Therapeutics, Inc. Aktie
German listing (Munich) of Celldex Therapeutics, Inc. · home listing NASDAQ:CLDX
Follow Celldex Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:CLDX
$30.10 USD +0.21 (+0.7%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CLDX
- Day range
- $29.20 – $30.12 USDOct 30, 2026
- Volume
- 870,775 sharesOct 30, 2026
- Market cap
- $2.36B USDAt the close on Oct 30, 2026 · price × 78.53M shares outstanding
- 52-week range
- $22.10 – $45.14 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $45.68M USDMedian day 932,842 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CLDX · Home | $30.10 USD | +0.21 (+0.7%) | 870,775 | $29.70 | $30.12 | $29.20 | $29.89 | Close on Oct 30, 2026 |
| Frankfurt:TCE2 | €26.40 EUR | +0.31 (+1.2%) | — | €26.40 | €26.40 | €26.40 | €26.09 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:CLDX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $30.10 | +0.21 | +0.7% | $29.70 | $30.12 | $29.20 | 870,775 | |
| $29.89 | +0.23 | +0.8% | $29.79 | $30.39 | $29.47 | 916,683 | |
| $29.66 | -0.49 | -1.6% | $29.63 | $30.02 | $28.92 | 899,157 | |
| $30.15 | +0.65 | +2.2% | $29.50 | $30.40 | $29.33 | 746,577 | |
| $29.50 | +0.25 | +0.9% | $29.90 | $29.90 | $28.99 | 593,361 | |
| $29.25 | +0.28 | +1.0% | $28.95 | $29.38 | $28.20 | 879,733 | |
| $28.97 | -0.40 | -1.4% | $29.08 | $29.73 | $28.49 | 877,932 | |
| $29.37 | -0.92 | -3.0% | $30.29 | $30.72 | $29.31 | 1,117,525 | |
| $30.29 | +0.62 | +2.1% | $29.99 | $30.82 | $29.61 | 1,100,405 | |
| $29.67 | +2.14 | +7.8% | $27.73 | $29.85 | $27.50 | 1,719,333 | |
| $27.53 | -1.40 | -4.8% | $28.89 | $28.89 | $27.47 | 997,900 | |
| $28.93 | +1.09 | +3.9% | $28.05 | $28.95 | $27.65 | 1,181,700 | |
| $27.84 | -0.41 | -1.5% | $28.49 | $28.73 | $27.68 | 1,044,300 | |
| $28.25 | -1.18 | -4.0% | $29.28 | $29.28 | $27.92 | 1,897,900 | |
| $29.43 | -0.46 | -1.5% | $29.61 | $30.03 | $28.99 | 596,400 | |
| $29.89 | +0.59 | +2.0% | $29.04 | $30.26 | $28.88 | 992,700 | |
| $29.30 | -1.13 | -3.7% | $30.07 | $30.10 | $28.63 | 3,950,400 | |
| $30.43 | -0.58 | -1.9% | $30.62 | $31.35 | $30.11 | 1,746,900 | |
| $31.01 | -1.58 | -4.8% | $32.68 | $32.68 | $30.85 | 1,768,200 | |
| $32.59 | +0.94 | +3.0% | $31.83 | $32.88 | $31.50 | 1,257,900 | |
| $31.65 | -0.53 | -1.6% | $32.26 | $32.54 | $30.98 | 2,404,700 | |
| $32.18 | -0.23 | -0.7% | $32.26 | $32.55 | $31.70 | 1,442,300 | |
| $32.41 | +0.77 | +2.4% | $31.71 | $32.76 | $31.45 | 2,502,000 | |
| $31.64 | +0.15 | +0.5% | $31.49 | $31.79 | $31.00 | 2,029,400 | |
| $31.49 | +0.39 | +1.3% | $31.06 | $32.15 | $30.38 | 1,824,100 | |
| $31.10 | -0.38 | -1.2% | $31.48 | $31.71 | $30.65 | 2,023,800 | |
| $31.48 | +0.36 | +1.2% | $31.48 | $31.66 | $30.59 | 2,297,500 | |
| $31.12 | -2.39 | -7.1% | $33.54 | $33.59 | $30.41 | 4,235,600 | |
| $33.51 | -4.38 | -11.6% | $36.60 | $38.39 | $30.39 | 12,888,900 | |
| $37.89 | -0.35 | -0.9% | $41.62 | $41.62 | $37.48 | 549,500 | |
| $38.24 | -0.74 | -1.9% | $38.87 | $38.87 | $37.54 | 2,081,900 | |
| $38.98 | +0.27 | +0.7% | $39.47 | $40.66 | $38.92 | 1,278,900 | |
| $38.71 | +0.20 | +0.5% | $38.59 | $39.21 | $38.25 | 1,001,400 | |
| $38.51 | -0.67 | -1.7% | $39.00 | $39.19 | $37.74 | 686,400 | |
| $39.18 | +2.28 | +6.2% | $37.40 | $39.42 | $37.27 | 1,000,200 | |
| $36.90 | -1.20 | -3.1% | $38.39 | $38.59 | $36.84 | 1,033,500 | |
| $38.10 | -0.68 | -1.8% | $38.78 | $38.86 | $37.75 | 949,000 | |
| $38.78 | -0.34 | -0.9% | $38.95 | $40.04 | $38.67 | 588,400 | |
| $39.12 | -0.56 | -1.4% | $38.78 | $39.87 | $38.50 | 834,300 | |
| $39.68 | +0.31 | +0.8% | $38.96 | $39.81 | $38.90 | 414,500 | |
| $39.37 | -0.11 | -0.3% | $39.50 | $39.89 | $38.95 | 418,000 | |
| $39.48 | +0.24 | +0.6% | $39.43 | $40.55 | $39.01 | 476,400 | |
| $39.24 | -0.39 | -1.0% | $39.13 | $39.90 | $38.94 | 542,500 | |
| $39.63 | +0.51 | +1.3% | $38.86 | $39.84 | $38.74 | 696,900 | |
| $39.12 | -1.34 | -3.3% | $40.33 | $40.57 | $39.04 | 424,900 | |
| $40.46 | -0.11 | -0.3% | $40.44 | $41.00 | $40.02 | 450,000 | |
| $40.57 | -0.65 | -1.6% | $41.18 | $42.12 | $40.06 | 540,700 | |
| $41.22 | +0.65 | +1.6% | $41.02 | $41.92 | $40.63 | 550,900 | |
| $40.57 | +0.19 | +0.5% | $40.16 | $40.98 | $39.53 | 416,900 | |
| $40.38 | +0.44 | +1.1% | $40.38 | $41.24 | $40.12 | 837,700 | |
| $39.94 | -1.76 | -4.2% | $41.40 | $42.00 | $39.45 | 1,002,500 | |
| $41.70 | -0.09 | -0.2% | $42.10 | $43.20 | $41.33 | 1,392,300 | |
| $41.79 | -0.13 | -0.3% | $41.29 | $42.36 | $41.03 | 999,000 | |
| $41.92 | -0.03 | -0.1% | $41.54 | $42.81 | $41.07 | 629,800 | |
| $41.95 | -0.66 | -1.5% | $42.23 | $42.35 | $40.88 | 849,400 | |
| $42.61 | -2.26 | -5.0% | $45.13 | $45.13 | $42.56 | 670,900 | |
| $44.87 | +0.54 | +1.2% | $44.40 | $45.14 | $43.80 | 1,594,600 | |
| $44.33 | +1.36 | +3.2% | $42.81 | $44.60 | $42.46 | 767,400 | |
| $42.97 | +1.26 | +3.0% | $41.71 | $43.21 | $41.41 | 727,600 | |
| $41.71 | +0.15 | +0.4% | $41.87 | $42.92 | $41.29 | 808,900 | |
| $41.56 | +0.50 | +1.2% | $41.12 | $41.74 | $40.84 | 799,100 | |
| $41.06 | +2.01 | +5.1% | $39.36 | $41.15 | $38.86 | 788,900 | |
| $39.05 | +1.36 | +3.6% | $37.69 | $39.34 | $37.54 | 1,027,500 | |
| $37.69 | -0.37 | -1.0% | $38.09 | $38.59 | $37.05 | 1,635,200 | |
| $38.06 | -0.43 | -1.1% | $38.50 | $38.65 | $37.15 | 875,700 | |
| $38.49 | +0.98 | +2.6% | $37.26 | $38.59 | $37.23 | 743,200 |
- Ticker
- Munich:TCE2
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Sep 22, 2026
Celldex Announces Positive Results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Studies of Barzolvolimab Which Met Primary and All Key Secondary Endpoints
Latest deck · Sep 22, 2026
Technical Presentation (September 2026)
Technical · 21 slides
Calls
Replays
Celldex Therapeutics (NASDAQ:CLDX) Q1 2025 Earnings Call
Thu, Jun 12, 2025 · 6:00 PM ET
Watch TranscriptCelldex Therapeutics (NASDAQ:CLDX) Q4 2021 Earnings Call
Mon, Feb 28, 2022 · 4:30 PM ET
Watch Transcript
Latest news
Celldex Announces Positive Results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Studies of Barzolvolimab Which Met Primary and All Key Secondary Endpoints
Sep 22, 2026
Closed $33.51 (-11.6%) on Sep 22, 2026
Celldex Reports Second Quarter Financial Results and Provides Corporate Update
Aug 6, 2026
Closed $41.71 (+0.4%) on Aug 7, 2026
Celldex Reports Results from Phase 2 Study of Barzolvolimab in Prurigo Nodularis
Jul 21, 2026
Closed $34.77 (-2.5%) on Jul 22, 2026
Celldex Announces Planned Transition of Chief Financial Officer
Jul 15, 2026
Closed $35.40 (-7.6%) on Jul 16, 2026
Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting
Jun 14, 2026
Closed $32.12 (+2.7%) on Jun 15, 2026
Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting
Jun 14, 2026
Closed $32.12 (+2.7%) on Jun 15, 2026
Celldex Announces Multiple Upcoming Presentations from Leading Mast Cell Targeting Pipeline at the Upcoming 2026 European Academy of Allergy and Clinical Immunology Annual Congress
Jun 10, 2026
Closed $29.96 (+2.1%) on Jun 11, 2026
Celldex Reports First Quarter Financial Results and Provides Corporate Update
May 7, 2026
Closed $33.97 (+2.0%) on May 8, 2026
Celldex to Present at Upcoming Investor Conference
Apr 13, 2026
Closed $33.33 (+2.3%) on Apr 14, 2026
Celldex Announces Proposed Public Offering of Common Stock
Apr 1, 2026
Closed $31.06 (-0.6%) on Apr 2, 2026
Decks
Technical Presentation (September 2026)
Technical · 21 slides · Sep 22, 2026
Technical Presentation (June 2026)
Technical · 13 slides · June 2026
Technical Presentation (June 2026)
Technical · 10 slides · June 2026
EAACI Congress 2025
Conference · 14 slides · Jun 13, 2025
Celldex Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 26 in the last 12 months · 146 in all · newest Sep 22, 2026 · oldest 2019
- Calls
- 2 calls with a replay · 2 with a transcript · latest Jun 12, 2025
- Decks
- 14 decks · latest Sep 22, 2026
Where Celldex Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CLDX · Home listing | NASDAQ | United States | USD |
| gettex:TCE2 | gettex | Germany | EUR |
| Lang & Schwarz:A2PEAB | Lang & Schwarz | Germany | EUR |
| LS Exchange:A2PEAB | LS Exchange | Germany | EUR |
| Tradegate:TCE2 | Tradegate | Germany | EUR |
| BOATS:CLDX | BOATS | United States | USD |
| BX Swiss:TCE1 | BX Swiss | Switzerland | CHF |
| Dusseldorf:TCE2 | Dusseldorf | Germany | EUR |
| Frankfurt:TCE2 | Frankfurt | Germany | EUR |
| Munich:TCE2 · This page | Munich | Germany | EUR |
| Stuttgart:TCE2 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Celldex Therapeutics, Inc.